@ozblue you and I must have bought into this company on the same day. I too bought because of the deal & didn't really ascribe any value to Goulamina.
The cap raise was at 16c, the share price sank as low as 13c post acquisition. No one could understand why the market didn't get it & value us higher. Considering it was Oct 31 the deal was announced, it took 60 days, the beginning of January before we climbed above 16c. I very much doubt if we'll be at present prices in 60 days time from now. I think management have proved themselves, they'll do a few investor briefings & the market will begin to understand. I missed yesterday's webinar, but totally get where management are coming from after watching the replay.
This is a buying opportunity, not sure if the Directors/Management are now out of the blackout period, if so I wouldn't at all be surprised to see them take advantage of these prices.
FFX Price at posting:
47.5¢ Sentiment: Buy Disclosure: Held
